Skip to main content

Table 1 Clinical data

From: In vivo measurement of stent length by using intravascular ultrasound

  Patients (n = 90)
Age (years) 66.6 ± 10.0
Sex (%)Men74 (82.2)
Women16 (17.8)
Smokers (%) 51 (56.7)
Hypertension (%) 60 (66.7)
Diabetes mellitus (%) 32 (35.6)
Dyslipidemia (%) 61 (67.8)
Family history (%) 14 (15.6)
Chronic stable angina pectoris (%) 39 (43.3)
Unstable angina pectoris (%) 29 (32.2)
Acute myocardial infarction (%) 22 (24.4)
Ejection fraction 0.62 ± 0.12
Statin (%) 52 (57.8)
β-Blocker (%) 27 (30)
Calcium antagonist (%) 39 (43.3)
ACE inhibitor (%) 21 (23.3)
ARB (%) 32 (35.5)
Cholesterol, mg/dl 190.06 ± 35.94
LDL cholesterol, mg/dl 120.28 ± 28.34
HDL cholesterol, mg/dl 48.44 ± 13.34
  1. Data are given as mean ± SD or percentage
  2. ACE angiotensin-converting enzyme, ARB angiotensin receptor blocker, β-blocker beta-blocker, HDL cholesterol high-density lipoprotein cholesterol, LDL cholesterol low-density lipoprotein cholesterol